K1 KEYVIT 50 mg tablets for dogs
K1 KEYVIT 50 mg tablets for dogs
Authorised
- Phytomenadione
Product identification
Medicine name:
K1 KEYVIT 50 mg tablets for dogs
KEYVIT 50 mg, tabletės šunims
Active substance:
- Phytomenadione
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Phytomenadione50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QB02BA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Box containing 2 aluminium and PVC-aluminium-oPA thermosealed blisters of 7 tablets
- Box containing 1 aluminium and PVC-aluminium-oPA thermosealed blister of 7 tablets
- Box containing 4 aluminium and PVC-aluminium-oPA thermosealed blisters of 7 tablets
- Box containing 3 aluminium and PVC-aluminium-oPA thermosealed blisters of 7 tablets
- Box containing 12 aluminium and PVC-aluminium-oPA thermosealed blisters of 7 tablets
- Box containing 5 aluminium and PVC-aluminium-oPA thermosealed blisters of 7 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Nextmune Italy S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/21/2689/001-006
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0358/001
Concerned member states:
-
Belgium
-
France
-
Greece
-
Italy
-
Latvia
-
Lithuania
-
Poland
-
Portugal
-
Romania
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
